TerminatedNot applicableNCT04104334
Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC
Studying Malignant hyperthermia of anesthesia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
- Principal Investigator
- Philippe PR Richebé, MD PhDCIUSSS Est de l'île de Montréal
- Intervention
- Remifentanil infusion, desflurane titration and fluid infusion will be guided by NOL index, BIS index and Flotrac EV1000 system respectively(drug)
- Enrollment
- 9 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montréal, Montreal East, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04104334 on ClinicalTrials.govOther trials for Malignant hyperthermia of anesthesia
Additional recruiting or active studies for the same condition.